Sobi Swedish Orphan Biovitrum AB (publ)
About Company
Sobi is a global biopharmaceutical company dedicated to transforming the lives of people living with rare diseases. We focus on developing breakthrough treatments that address unmet medical needs and improve everyday life for patients worldwide.
Founded in Sweden with early work in haemophilia, Sobi has grown into an innovative leader in rare diseases with a global presence. We identify scientific opportunities, turn brilliant ideas into therapies, and ensure patients around the world have access to new treatments.
Our global team and operational network form the foundation of our success, driving innovation, collaboration, and patient-centered solutions.
Our Values
Care: Our dedication, knowledge, and passion guide everything we do.
Ownership: We take responsibility, encourage initiative, and learn from experience.
Urgency: We act swiftly without compromising quality—patients cannot wait.
Partnership: Collaboration is key, both within Sobi and with external partners.
Ambition: We set high goals and strive to achieve them in everything we do.
Focus on Rare Diseases
Although individual rare diseases are uncommon, collectively they affect around 400 million people worldwide. Sobi is committed to making a meaningful difference in the lives of these patients by developing innovative therapies and expanding global access.
